Brevan Howard Capital Management LP United Therapeutics Corp Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 2,881 shares of UTHR stock, worth $1.34 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,881
Previous 3,438
16.2%
Holding current value
$1.34 Million
Previous $987,000
22.29%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
833Shares Held
41.8MCall Options Held
1.56MPut Options Held
2.86M-
Black Rock Inc. New York, NY5.47MShares$2.55 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$2.06 Billion0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.17MShares$1.01 Billion1.29% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$943 Million11.58% of portfolio
-
State Street Corp Boston, MA1.92MShares$897 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $21.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...